Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Lydia Wang-Lakshman, n/a
Clinical Trial Leader
Novartis
Poster(s):
044: The Role of Exposure-Response Analyses in Determination of Recommended Dose for Expansion in a Phase I/Ib Study of NIZ985 Alone & in Combination With Spartalizumab in Cancer Patients
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
